Menu

Portfolio overview

We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2014, the value of the top 30 investments in our portfolio stood at £226.1 million.

Portfolio subsectors

  • Therapeutics
  • Medtech
  • Engineering/Materials
  • ICT/Digital
£226.1m Total

Sector
Therapeutics
Investment amount
£25.5m
Investment stage
Listed

Overview

A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies



Sector
Engineering & Materials
Investment amount
Investment stage
Organic Growth

Overview

Intelligent air quality sensing



Sector
Engineering & Materials
Investment amount
£22.4m
Investment stage
post-Series A

Overview

Unique silicon anodes for next generation Lithium-ion batteries with improved energy density and cycle life



Sector
Medtech
Investment amount
£9.8m
Investment stage
post-Series A

Overview

3D stent technology intended to improve the biomechanical and blood flow characteristics of vascular stents


Case studies